isradipine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Parkinson's disease is a common neurodegenerative disorder of unknown cause." | 2.44 | Calcium, ageing, and neuronal vulnerability in Parkinson's disease. ( Surmeier, DJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilijic, E | 1 |
| Guzman, JN | 1 |
| Surmeier, DJ | 2 |
1 review available for isradipine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
Topics: Aging; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Dopamine; Humans; Isradipine; N | 2007 |
1 other study available for isradipine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Disease Models, Anima | 2011 |